We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

46 hedge funds and large institutions have $14.5M invested in RVL Pharmaceuticals plc Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less funds holding

Funds holding: 55 → 46 (-9)

43% less capital invested

Capital invested by funds: $25.6M → $14.5M (-$11.1M)

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

73% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 22

Holders
46
Holders Change
-9
Holders Change %
-16.36%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Rovida Advisors
Florida
+$919K
2
Millennium Management
Millennium Management
New York
+$490K
3
E
Ergoteles
New York
+$175K
4
HF
HRT Financial
New York
+$110K
5
HW
Hancock Whitney
Mississippi
+$108K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.52M
2
SCM
Sio Capital Management
New York
-$1.69M
3
WCM
Wedge Capital Management
North Carolina
-$1.11M
4
Morgan Stanley
Morgan Stanley
New York
-$802K
5
AllianceBernstein
AllianceBernstein
Tennessee
-$703K
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
51
Arrowstreet Capital
Massachusetts
– -$123K -37,712 Closed
FA
52
Forefront Analytics
Pennsylvania
– -$99K -30,118 Closed
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
– -$62K -19,146 Closed
MAM
54
Martingale Asset Management
Massachusetts
– -$62K -18,800 Closed
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
– -$53K -16,410 Closed
AQR Capital Management
56
AQR Capital Management
Connecticut
– -$53K -16,121 Closed
Ohio Public Employees Retirement System (OPERS)
57
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$42K -12,804 Closed
RA
58
Royce & Associates
New York
– -$39K -12,115 Closed
Invesco
59
Invesco
Georgia
– -$34K -10,486 Closed
AIG
60
American International Group
New York
– -$24 -7,400 Closed
Legal & General Group
61
Legal & General Group
United Kingdom
– -$5K -1,581 Closed
AIP
62
Ameritas Investment Partners
Nebraska
– -$3K -800 Closed
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
– -$1.19K -389 -78%
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
– -$1K -374 Closed
1 2
3

RVLP Hedge Fund Activity: Q2 2021 in Review

46 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q2 2021, worth a combined $14.5M — down 43% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RVLP and 10 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 6 added.

The largest buyer was Rovida Advisors, opening a new position worth an estimated $919K. The largest seller was BlackRock, cutting an estimated $3.52M.

  • 46 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q2 2021, down from 55 in Q1 2021.
  • Funds reported $14.5M of RVL Pharmaceuticals plc Ordinary Shares stock for Q2 2021, down 43% quarter-over-quarter.
  • 10 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q2 2021 and 19 closed out, a net change of -9 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q2 2021 was Rovida Advisors, an estimated $919K added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q2 2021 was BlackRock, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2021.